Double-Take results point to stabilization, says Oppenheimer
Oppenheimer believes Double-Take's two consecutive quarters of in-line results point to signs of stabilization in the company's target markets. The firm raised its target on shares to $12 from $11 and maintains an Outperform rating on the stock. :theflyonthewall.com
News For DBTK From The Last 14 Days
Check below for free stories on DBTK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
